Is there a role for the irreversible epidermal growth factor receptor inhibitor EKB-569 in the treatment of cancer? A mutation-driven question
- PMID: 16710019
- DOI: 10.1200/JCO.2005.05.3785
Is there a role for the irreversible epidermal growth factor receptor inhibitor EKB-569 in the treatment of cancer? A mutation-driven question
Comment on
-
Phase I study of EKB-569, an irreversible inhibitor of the epidermal growth factor receptor, in patients with advanced solid tumors.J Clin Oncol. 2006 May 20;24(15):2252-60. doi: 10.1200/JCO.2005.01.8960. J Clin Oncol. 2006. PMID: 16710023 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials